Myositides : What is the current situation?

Rösler, Kai Michael; Scheidegger, Olivier (2015). Myositides : What is the current situation? Zeitschrift für Rheumatologie, 74(6), pp. 496-506. Springer-Medizin-Verlag 10.1007/s00393-014-1547-0

Preview

Text art%3A10.1007%2Fs00393-014-1547-0.pdf - Published Version Available under License Publisher holds Copyright. Download (963kB) | Preview

This article gives a review of the classification, diagnostic procedures and treatment of idiopathic inflammatory myopathies from a neurological point of view. The myositis syndromes can be subdivided into four groups, polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM) and necrotizing myopathy (NM), which substantially differ clinically and pathophysiologically. Myositis may also occur in association with cancer or autoimmune systemic diseases (overlap syndrome). Diagnosis of inflammatory myopathies is based on clinical symptoms, determination of creatine phosphokinase and acute phase parameters in blood (e.g. C-reactive protein and erythrocyte sedimentation rate), electromyography results and findings of magnetic resonance imaging (MRI) in muscle. A muscle biopsy is mandatory to confirm the diagnosis. High quality randomized controlled trials of treatment regimens for inflammatory myopathies are sparse; however, empirical experience indicates a clear effectiveness of immunosuppressive treatment of PM, DM and NM.

Interest & Impact

Downloads

290 since deposited on 05 Oct 2015
240 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item